摘要
我们对接受自血光量子疗法治疗的颅脑损伤病人外周血脆性位点（ＦＳ）进行分析，并与正常人做对照。结果对照组与实验组治疗前比较无显著性差异（Ｐ＞０．０５）。说明此病与ＦＳ无关。实验组治疗后３年与治疗前比较有显著性差异（Ｐ＜０．０５）；治疗结束时与治疗前比较有高度显著性差异（Ｐ＜０．０１）。治疗后３年与治疗结束时有显著性差异（Ｐ＜０．０５）。前二者说明ＦＳ的升高与紫外线照射血液回输有关，后者说明３年后ＤＮＡ有恢复趋势。
we analysed the effect of autohemic ultraviolet therapy to skull injury’s peripheral blood fragile site(FS)and compared the experimental group with the contrast one.The result was like this,the FS of the contrast group and the experimental group before treatment had not significant difference(P>0.05).It showed that skull injury had nothing to do with FS.After 3 years treatment,we compared the experimental group’s result with that before treatment.We found that FS had significant different(P<0.05).At the end of treatment FS had obviously significant difference(p<0.01),Then we compared the result with that after 3 years treatment,FS had significant difference.Conclusion:The first and second result showed that the increasing of FS had relation to ultraviolet postradiation autohemic infusion.The third showed that DNA had resuming tendency.
出处
《中国优生与遗传杂志》
1996年第1期56-57,共2页
Chinese Journal of Birth Health & Heredity
